bluebird bio (NASDAQ:BLUE) Raised to “Neutral” at JPMorgan Chase & Co.
bluebird bio (NASDAQ:BLUE – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research report issued on Monday, Marketbeat.com reports. A number of other equities analysts also recently commented on BLUE. StockNews.com began coverage on bluebird bio in a report on […]
bluebird bio (NASDAQ:BLUE – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research report issued on Monday, Marketbeat.com reports. A number of other equities analysts also recently commented on BLUE. StockNews.com began coverage on bluebird bio in a report on […]
